Pharmaceuticals
GSK’s former China head charged with bribery
14 May 2014
GSK said that some of its senior Chinese executives appeared to have broken the law
AstraZeneca snubs Pfizer’s “opportunistic” bid
13 May 2014
Botox maker Allergan rejects Valeant's $45.7-b hostile bid
12 May 2014
Allergan Inc today rejected the hostile takeover offer from Canada’s Valeant Pharmaceuticals International Inc, saying that the $45.7-billion bid substantially undervalued the company
Cipla buys 14.6% stake in Chase Pharma to support Alzheimer treatment
12 May 2014
The disease costs the US alone $203 billion annually with projections to reach $1.2 trillion by 2050
.webp)
.webp)
